Prospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jan 14, 2025; 31(2): 101292
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.101292
Figure 4
Figure 4 Longitudinal association between vedolizumab serum trough concentrations at 3 distinct time points. A: Clinical; B: Endoscopy; C: Histology; D: Histo-endoscopic outcomes over 48 weeks.